TC BioPharm Announces Grant Funding in Collaboration with Queen Mary University of London (QMUL)
15 September 2023
Life Science
EDINBURGH, Scotland, Sept. 5, 2023 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, is proud to announce it has entered into …
The Cancer Platform Announces Seerave Foundation as latest Co-Founder
6 September 2023
Life Science
Transformational grant from Seerave Foundation powers the next phase of the Cancer Platforms’ development The Cancer Awareness Trust is delighted to announce a new Co-Founder, David Rees. David is the first philanthropist to come in alongside our Founders. Founders Professor Sir …
The Cancer Awareness Trust announce Andy Taylor, Founding Member of Duran Duran, as latest Ambassador
11 August 2023
Life Science
Andy Taylor, guitarist, writer and founding member of Duran Duran becomes an Ambassador for UK Cancer Charity, The Cancer Awareness Trust, founded by Prof. Sir Chris Evans. In November 2022, Andy Taylor, guitarist, writer & founding member of Duran Duran revealed …
The Big Cancer52 Conversation
28 June 2023
Life Science
The Big Cancer52 Conversation kicked off this month at Level39, bringing together delegates from cross-sector organisations across the wider rare and less common cancer community. The day was opened by Canary Wharf Group CEO, Shobi Khan, and led by Cancer52 CEO, Jane …
Canary Wharf Attracts Life Sciences focused start-ups and scale-ups to its tech community at Level39
25 April 2023
Life Science
Latest members at Level39 include TC BioPharm, Neural Rays AI, L Base, Sanius Health and The Cancer Awareness Trust Existing life science companies at the specialist co-working and office hub include Congenica, whose CFO will be speaking at this …
Level39 hosts first Health & Life Science Meet-up in Canary Wharf
3 April 2023
Life Science
On Wednesday 22 March, Level39 hosted it's first Health & Life Science Meet-up in collaboration with parent company, Canary Wharf Group, alongside London & Partners and Kadans Science Partner. The event brought together 120 + people, all with the common interest …
Foxberry expands the Sustainability Consensus index range with new indices licensed to Legal & General Investment Management for new core ETFs
31 October 2022
Life Science
London, 31 October 2022: Foxberry Ltd, the provider of financial indices and front-office technology for the financial sector, today announced the expansion of its Sustainability Consensus index family with two regional indices licensed to Legal & General Investment Management for …
PDS completes End-of-Phase 2 meeting with FDA
5 October 2022
Life Science
Technology
NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB), announced that it has successfully completed an End-of-Phase 2 meeting with the U.S. Food and …
NetScientific announces completion of acquisition of 30% stake in Vortex Biotech Holdings (Vortex) and appointment of new Vortex CEO
16 August 2022
Life Science
Technology
To drive commercial opportunities and develop an industry leading solution London August 2022 NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, is pleased to announce, further to its announcement of 6 May 2022, that it …
Proposed Placing of new ordinary shares to raise at least £1.5 million
22 June 2022
Life Science
NetScientific PLC, the life sciences and sustainability technology investment and commercialisation group, is pleased to announce that the Company is carrying out an equity fundraising to raise at least £1.5 million (the “Placing”), before expenses, via the issue of an …